{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:27:43Z","timestamp":1791592063737,"version":"4.3.4"},"reference-count":104,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.drudis.2016.10.017","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T15:31:57Z","timestamp":1479915117000},"page":"234-248","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts"],"prefix":"10.1016","volume":"22","author":[{"given":"Nicolau B.","family":"da Cunha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole B.","family":"Cobacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane F.C.","family":"Viana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loiane A.","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila B.O.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan S.M.","family":"Dohms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur C.R.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"de la Fuente-N\u00fa\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1003-1049","authenticated-orcid":false,"given":"Fabr\u00edcio F.","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oct\u00e1vio L.","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simoni C.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2016.10.017_bib0525","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.idc.2016.02.001","article-title":"Overview: global and local impact of antibiotic resistance","volume":"30","author":"Watkins","year":"2016","journal-title":"Infect. Dis. Clin. N. Am."},{"key":"10.1016\/j.drudis.2016.10.017_bib0530","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.euprot.2014.05.003","article-title":"The emergence of peptides in the pharmaceutical business: from exploration to exploitation","volume":"4","author":"Uhlig","year":"2014","journal-title":"EuPA Open Proteomics"},{"key":"10.1016\/j.drudis.2016.10.017_bib0535","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.drup.2016.04.002","article-title":"Mechanisms and consequences of bacterial resistance to antimicrobial peptides","volume":"26","author":"Andersson","year":"2016","journal-title":"Drug Resist. Updates"},{"key":"10.1016\/j.drudis.2016.10.017_bib0540","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s13054-016-1320-7","article-title":"Antibiotic strategies in the era of multidrug resistance","volume":"20","author":"Karam","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.drudis.2016.10.017_bib0545","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tibtech.2011.05.001","article-title":"The expanding scope of antimicrobial peptide structures and their modes of action","volume":"29","author":"Nguyen","year":"2011","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0550","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1002\/mbo3.248","article-title":"The antifungal plant defensin AhPDF1.1b is a beneficial factor involved in adaptive response to zinc overload when it is expressed in yeast cells","volume":"4","author":"Mith","year":"2015","journal-title":"MicrobiologyOpen"},{"key":"10.1016\/j.drudis.2016.10.017_bib0555","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1128\/AAC.03937-14","article-title":"Engineered cationic antimicrobial peptides to overcome multidrug resistance by ESKAPE pathogens","volume":"59","author":"Deslouches","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.10.017_bib0560","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1016\/j.vaccine.2005.01.006","article-title":"Magnifection: a new platform for expressing recombinant vaccines in plants","volume":"23","author":"Gleba","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2016.10.017_bib0565","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1093\/hmg\/ddu125","article-title":"CRISPR\/Cas9 for genome editing: progress, implications and challenges","volume":"23","author":"Zhang","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.drudis.2016.10.017_bib0570","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3390\/ph9030059","article-title":"Antimicrobial peptides targeting Gram-positive bacteria","volume":"9","author":"Malanovic","year":"2016","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2016.10.017_bib0575","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.bbamem.2015.11.004","article-title":"Gram-positive bacterial cell envelopes: the impact on the activity of antimicrobial peptides","volume":"1858","author":"Malanovic","year":"2016","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.drudis.2016.10.017_bib0580","first-page":"46","article-title":"Antimicrobial peptides and their pore\/ion channel properties in neutralization of pathogenic microbes","volume":"16","author":"Shruti","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.drudis.2016.10.017_bib0585","doi-asserted-by":"crossref","first-page":"3078","DOI":"10.1016\/j.bbamem.2015.02.017","article-title":"Understanding bacterial resistance to antimicrobial peptides: from the surface to deep inside","volume":"1848","author":"Maria-Neto","year":"2015","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.drudis.2016.10.017_bib0590","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3389\/fmicb.2016.00381","article-title":"Induced bacterial cross-resistance toward host antimicrobial peptides: a worrying phenomenon","volume":"7","author":"Fleitas","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0595","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fmicb.2014.00147","article-title":"New edge of antibiotic development: antimicrobial peptides and corresponding resistance","volume":"5","author":"Parachin","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0600","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1128\/AAC.02182-12","article-title":"Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus","volume":"57","author":"Mishra","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.10.017_bib0605","doi-asserted-by":"crossref","first-page":"11584","DOI":"10.1074\/jbc.M114.554444","article-title":"Cardiolipin prevents membrane translocation and permeabilization by daptomycin","volume":"289","author":"Zhang","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.10.017_bib0610","doi-asserted-by":"crossref","first-page":"7462","DOI":"10.1128\/AAC.03422-14","article-title":"Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides","volume":"58","author":"Bayer","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.10.017_bib0615","doi-asserted-by":"crossref","first-page":"e43958","DOI":"10.1371\/journal.pone.0043958","article-title":"Daptomycin resistance in enterococci is associated with distinct alterations of cell membrane phospholipid content","volume":"7","author":"Mishra","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2016.10.017_bib0620","doi-asserted-by":"crossref","first-page":"6719","DOI":"10.1128\/JB.187.19.6719-6725.2005","article-title":"d-Alanylation of teichoic acids promotes group A Streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion","volume":"187","author":"Kristian","year":"2005","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0625","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1146\/annurev.biochem.71.110601.135414","article-title":"Lipopolysaccharide endotoxins","volume":"71","author":"Raetz","year":"2002","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.drudis.2016.10.017_bib0630","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1021\/cb500438x","article-title":"Antimicrobial peptide resistance of Vibrio cholerae results from an LPS modification pathway related to nonribosomal peptide synthetases","volume":"9","author":"Henderson","year":"2014","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0635","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.4049\/jimmunol.1101240","article-title":"A metalloproteinase karilysin present in the majority of Tannerella forsythia isolates inhibits all pathways of the complement system","volume":"188","author":"Jusko","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0640","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1096\/fj.07-093963","article-title":"A group B streptococcal pilus protein promotes phagocyte resistance and systemic virulence","volume":"22","author":"Maisey","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2016.10.017_bib0645","doi-asserted-by":"crossref","first-page":"15336","DOI":"10.1074\/jbc.274.22.15336","article-title":"Protein GRAB of Streptococcus pyogenes regulates proteolysis at the bacterial surface by binding \u03b12-macroglobulin","volume":"274","author":"Rasmussen","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.drudis.2016.10.017_bib0650","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1601-1546.2012.00277.x","article-title":"Bacterial biofilm: structure, function, and antimicrobial resistance","volume":"22","author":"Dufour","year":"2010","journal-title":"Endod. Top."},{"key":"10.1016\/j.drudis.2016.10.017_bib0655","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.drudis.2014.10.003","article-title":"Peptide therapeutics: current status and future directions","volume":"20","author":"Fosgerau","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2016.10.017_bib0660","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock","year":"2006","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0665","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1080\/13543776.2016.1176149","article-title":"Antimicrobial peptides (AMPs) as drug candidates: a patent review (2003\u20132015)","volume":"26","author":"Kosikowska","year":"2016","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.drudis.2016.10.017_bib0670","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/psc.1167","article-title":"Quality specifications for peptide drugs: a regulatory-pharmaceutical approach","volume":"15","author":"Vergote","year":"2009","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.drudis.2016.10.017_bib0675","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nbt.2572","article-title":"Antimicrobial peptides stage a comeback","volume":"31","author":"Fox","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0680","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2016.10.017_bib0685","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1128\/AAC.02218-12","article-title":"Rational design of engineered cationic antimicrobial peptides consisting exclusively of arginine and tryptophan, and their activity against multidrug-resistant pathogens","volume":"57","author":"Deslouches","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.10.017_bib0690","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nrmicro1098","article-title":"Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?","volume":"3","author":"Brogden","year":"2005","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0695","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.bbamem.2010.04.004","article-title":"Antimicrobial peptides in toroidal and cylindrical pores","volume":"1798","author":"Mihajlovic","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.drudis.2016.10.017_bib0700","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1128\/AAC.02972-15","article-title":"Novel engineered peptides of a phage lysin as effective antimicrobials against multidrug resistant, Acinetobacter baumannii","volume":"60","author":"Thandar","year":"2016","journal-title":"Antimicrob. Agents Chemother"},{"key":"10.1016\/j.drudis.2016.10.017_bib0705","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1155\/2013\/675391","article-title":"Antimicrobial peptides: versatile biological properties","volume":"2013","author":"Pushpanathan","year":"2013","journal-title":"Int. J. Pept."},{"key":"10.1016\/j.drudis.2016.10.017_bib0710","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1093\/bioinformatics\/btm323","article-title":"Interaction-site prediction for protein complexes: a critical assessment","volume":"23","author":"Zhou","year":"2007","journal-title":"Bioinformatics"},{"key":"10.1016\/j.drudis.2016.10.017_bib0715","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.tibtech.2005.09.003","article-title":"Biopharmaceutical production in plants: problems, solutions and opportunities","volume":"23","author":"Gomord","year":"2005","journal-title":"Trends Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0720","series-title":"Recombinant Proteins from Plants: Methods and Protocols","first-page":"239","article-title":"N-glycosylation of plant recombinant pharmaceuticals","author":"Bardor","year":"2009"},{"key":"10.1016\/j.drudis.2016.10.017_bib0725","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1467-7652.2004.00062.x","article-title":"Production and glycosylation of plant-made pharmaceuticals: the antibodies as a challenge","volume":"2","author":"Gomord","year":"2004","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.drudis.2016.10.017_bib0730","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1467-7652.2008.00370.x","article-title":"Expression of rat \u03b2(1,4)-N-acetylglucosaminyltransferase III in Nicotiana tabacum remodels the plant-specific N-glycosylation","volume":"7","author":"Frey","year":"2009","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.drudis.2016.10.017_bib0735","doi-asserted-by":"crossref","first-page":"e5285","DOI":"10.1371\/journal.pone.0005285","article-title":"End-tagging of ultra-short antimicrobial peptides by W\/F stretches to facilitate bacterial killing","volume":"4","author":"Pasupuleti","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2016.10.017_bib0740","doi-asserted-by":"crossref","first-page":"5070","DOI":"10.1021\/acsami.5b03697","article-title":"Engineered chimeric peptides as antimicrobial surface coating agents toward infection-free implants","volume":"8","author":"Yazici","year":"2016","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.drudis.2016.10.017_bib0745","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.chembiol.2015.01.002","article-title":"d-Enantiomeric peptides that eradicate wild-type and multi-drug resistant biofilms and protect against lethal Pseudomonas aeruginosa infections","volume":"22","author":"de la Fuente-N\u00fa\u00f1ez","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0750","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1016\/S0006-3495(01)75872-9","article-title":"Membrane insertion and orientation of polyalanine peptides: a (15)N solid-state NMR spectroscopy investigation","volume":"81","author":"Bechinger","year":"2001","journal-title":"Biophys. J."},{"key":"10.1016\/j.drudis.2016.10.017_bib0755","doi-asserted-by":"crossref","first-page":"e47047","DOI":"10.1371\/journal.pone.0047047","article-title":"Structural and functional characterization of a multifunctional alanine-rich peptide analogue from Pleuronectes americanus","volume":"7","author":"Migliolo","year":"2012","journal-title":"PLoS ONE"},{"issue":"Suppl.","key":"10.1016\/j.drudis.2016.10.017_bib0760","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.addr.2012.09.025","article-title":"Chemistry for peptide and protein PEGylation","volume":"64","author":"Roberts","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.drudis.2016.10.017_bib0765","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1021\/bm500246w","article-title":"PEG\u2013peptide conjugates","volume":"15","author":"Hamley","year":"2014","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.drudis.2016.10.017_bib0770","doi-asserted-by":"crossref","first-page":"10199","DOI":"10.1038\/ncomms10199","article-title":"Efficient backbone cyclization of linear peptides by a recombinant asparaginyl endopeptidase","volume":"6","author":"Harris","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.drudis.2016.10.017_bib0775","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/co300136j","article-title":"Global analysis of peptide cyclization efficiency","volume":"15","author":"Thakkar","year":"2013","journal-title":"ACS Comb. Sci."},{"key":"10.1016\/j.drudis.2016.10.017_bib0780","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1016\/j.bbamem.2014.06.012","article-title":"The effects of the C-terminal amidation of mastoparans on their biological actions and interactions with membrane-mimetic systems","volume":"1838","author":"da Silva","year":"2014","journal-title":"Biochim. Biophys. Acta Biomembr."},{"key":"10.1016\/j.drudis.2016.10.017_bib0785","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.3390\/ph6081055","article-title":"Characterization of antimicrobial peptides toward the development of novel antibiotics","volume":"6","author":"Aoki","year":"2013","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.drudis.2016.10.017_bib0790","doi-asserted-by":"crossref","first-page":"12280","DOI":"10.3390\/molecules190812280","article-title":"Antifungal plant defensins: mechanisms of action and production","volume":"19","author":"Vriens","year":"2014","journal-title":"Molecules"},{"key":"10.1016\/j.drudis.2016.10.017_bib0795","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12934-016-0502-y","article-title":"Lanthipeptides: chemical synthesis versus in vivo biosynthesis as tools for pharmaceutical production","volume":"15","author":"Ongey","year":"2016","journal-title":"Microb. Cell Factor."},{"key":"10.1016\/j.drudis.2016.10.017_bib0800","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev.biophys.34.040204.144700","article-title":"Chemical synthesis of proteins","volume":"34","author":"Nilsson","year":"2005","journal-title":"Annu. Rev. Biophys. Biomol. Struct."},{"key":"10.1016\/j.drudis.2016.10.017_bib0805","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.drudis.2009.10.009","article-title":"Synthetic therapeutic peptides: science and market","volume":"15","author":"Vlieghe","year":"2010","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.drudis.2016.10.017_bib0810","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01703433","volume":"9","author":"Becker","year":"1994","journal-title":"Virus Genes"},{"key":"10.1016\/j.drudis.2016.10.017_bib0815","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.peptides.2012.09.020","article-title":"Expression systems for heterologous production of antimicrobial peptides","volume":"38","author":"Parachin","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.drudis.2016.10.017_bib0820","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fmicb.2013.00321","article-title":"Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides","volume":"4","author":"Mulder","year":"2013","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0825","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713680590968637","article-title":"A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Eye Res."},{"key":"10.1016\/j.drudis.2016.10.017_bib0830","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12223-013-0280-4","article-title":"Plant antimicrobial peptides","volume":"59","author":"Nawrot","year":"2013","journal-title":"Folia Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0835","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.pbi.2004.01.003","article-title":"Engineering viral expression vectors for plants: the \u2018full virus\u2019 and the \u2018deconstructed virus\u2019 strategies","volume":"7","author":"Gleba","year":"2004","journal-title":"Curr. Opin. Plant Biol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0840","series-title":"Plant Viral Vectors","first-page":"155","article-title":"Plant viral vectors for delivery by Agrobacterium","author":"Gleba","year":"2014"},{"key":"10.1016\/j.drudis.2016.10.017_bib0845","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.copbio.2007.03.002","article-title":"Viral vectors for the expression of proteins in plants","volume":"18","author":"Gleba","year":"2007","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0850","doi-asserted-by":"crossref","first-page":"4154","DOI":"10.1172\/JCI72992","article-title":"Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR\u2013Cas9","volume":"124","author":"Gupta","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.drudis.2016.10.017_bib0855","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/jxb\/eru429","article-title":"The CRISPR\u2013Cas system for plant genome editing: advances and opportunities","volume":"66","author":"Kumar","year":"2015","journal-title":"J. Exp. Bot."},{"key":"10.1016\/j.drudis.2016.10.017_bib0860","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.biotechadv.2014.12.006","article-title":"The CRISPR\/Cas9 system for plant genome editing and beyond","volume":"33","author":"Bortesi","year":"2015","journal-title":"Biotechnol. Adv."},{"key":"10.1016\/j.drudis.2016.10.017_bib0865","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.cell.2014.05.010","article-title":"Development and applications of CRISPR\u2013Cas9 for genome engineering","volume":"157","author":"Hsu","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2016.10.017_bib0870","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.cell.2013.08.021","article-title":"Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity","volume":"154","author":"Ran","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.drudis.2016.10.017_bib0875","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/nbt.2675","article-title":"CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering","volume":"31","author":"Mali","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0880","series-title":"Antimicrobial Resistance: Tackling a Crisis for the Health and Wealth of Nations","author":"O\u2019Neill","year":"2014"},{"key":"10.1016\/j.drudis.2016.10.017_bib0885","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fmicb.2016.00882","article-title":"The Developing world urgently needs phages to combat pathogenic bacteria","volume":"7","author":"Nagel","year":"2016","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0890","doi-asserted-by":"crossref","first-page":"6775","DOI":"10.1046\/j.1432-1033.2000.01770.x","article-title":"Isolation and characterization of recombinant antibody fragments against CDC2a from Arabidopsis thaliana","volume":"267","author":"Eeckhout","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.drudis.2016.10.017_bib0895","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1080\/13550280390218454","article-title":"Development of a recombinant vaccine against Japanese encephalitis","volume":"9","author":"Kaur","year":"2003","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13568-015-0129-0","article-title":"Production of a modified peptide clavanin in Pichia pastoris: cloning, expression, purification and in vitro activities","volume":"5","author":"Mulder","year":"2015","journal-title":"AMB Express"},{"key":"10.1016\/j.drudis.2016.10.017_bib0905","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1096\/fj.14-269860","article-title":"Cm-p5: an antifungal hydrophilic peptide derived from the coastal mollusk Cenchritis muricatus (Gastropoda: Littorinidae)","volume":"29","author":"L\u00f3pez-Abarrategui","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.drudis.2016.10.017_bib0910","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/bit.25003","article-title":"Design of short membrane selective antimicrobial peptides containing tryptophan and arginine residues for improved activity, salt-resistance, and biocompatibility","volume":"111","author":"Saravanan","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.drudis.2016.10.017_bib0915","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0264-410X(02)00605-9","article-title":"Corn as a production system for human and animal vaccines","volume":"21","author":"Streatfield","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2016.10.017_bib0920","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1073\/pnas.0438037100","article-title":"A plant signal peptide-hepatitis B surface antigen fusion protein with enhanced stability and immunogenicity expressed in plant cells","volume":"100","author":"Sojikul","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.10.017_bib0925","doi-asserted-by":"crossref","first-page":"11128","DOI":"10.1073\/pnas.96.20.11128","article-title":"Transient expression of a tumor-specific single-chain fragment and a chimeric antibody in tobacco leaves","volume":"96","author":"Vaquero","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.10.017_bib0930","doi-asserted-by":"crossref","first-page":"9901","DOI":"10.1021\/jf061848v","article-title":"Biochemical safety evaluation of transgenic rice seeds expressing T cell epitopes of Japanese cedar pollen allergens","volume":"54","author":"Takagi","year":"2006","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.drudis.2016.10.017_bib0935","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.49.1.316-322.2005","article-title":"De novo generation of cationic antimicrobial peptides: influence of length and tryptophan substitution on antimicrobial activity","volume":"49","author":"Deslouches","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.10.017_bib0940","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1203\/01.pdr.0000250043.90468.c2","article-title":"Cathepsin-G interferes with clearance of Pseudomonas aeruginosa from mouse lungs","volume":"61","author":"Sedor","year":"2007","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.drudis.2016.10.017_bib0945","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.1016\/j.actbio.2012.11.004","article-title":"Biological response on a titanium implant-grade surface functionalized with modular peptides","volume":"9","author":"Yazici","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.drudis.2016.10.017_bib0950","doi-asserted-by":"crossref","first-page":"36","DOI":"10.12688\/f1000research.2-36.v1","article-title":"Modulation of proinflammatory activity by the engineered cationic antimicrobial peptide WLBU-2","volume":"2","author":"Paranjape","year":"2013","journal-title":"F1000 Res."},{"key":"10.1016\/j.drudis.2016.10.017_bib0955","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.leukres.2003.10.021","article-title":"A phase III, randomized, double-blind, placebo-controlled, study of iseganan for the reduction of stomatitis in patients receiving stomatotoxic chemotherapy","volume":"28","author":"Giles","year":"2004","journal-title":"Leuk. Res."},{"key":"10.1016\/j.drudis.2016.10.017_bib0960","doi-asserted-by":"crossref","first-page":"79","DOI":"10.2165\/00128071-200405020-00002","article-title":"Topical antibacterial treatments for acne vulgaris: comparative review and guide to selection","volume":"5","author":"Tan","year":"2004","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0965","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/AAC.48.8.3112-3118.2004","article-title":"Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity","volume":"48","author":"Sader","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.drudis.2016.10.017_bib0970","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1211\/0022357022971","article-title":"Histatins: antimicrobial peptides with therapeutic potential","volume":"56","author":"Kavanagh","year":"2004","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0975","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/sj.embor.embor748","article-title":"The big and small of drug discovery","volume":"4","author":"Moore","year":"2003","journal-title":"EMBO Rep."},{"key":"10.1016\/j.drudis.2016.10.017_bib0980","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrmicro908","article-title":"Can innate immunity be enhanced to treat microbial infections?","volume":"2","author":"Finlay","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0985","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1467-7652.2006.00221.x","article-title":"Suspension-cultured BY-2 tobacco cells produce and mature immunologically active house dust mite allergens","volume":"5","author":"Lienard","year":"2007","journal-title":"Plant Biotechnol. J."},{"key":"10.1016\/j.drudis.2016.10.017_bib0990","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039463200902200115","article-title":"Plant-derived recombinant F1, V, and F1-V fusion antigens of Yersinia pestis activate human cells of the innate and adaptive immune system","volume":"22","author":"Del Prete","year":"2009","journal-title":"Int. J. Immunopathol. Pharmacol."},{"key":"10.1016\/j.drudis.2016.10.017_bib0995","doi-asserted-by":"crossref","first-page":"3358","DOI":"10.1073\/pnas.92.8.3358","article-title":"Immunogenicity of transgenic plant-derived hepatitis B surface antigen","volume":"92","author":"Thanavala","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.10.017_bib1000","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1385\/MB:20:2:131","article-title":"Production of HIV-1 p24 protein in transgenic tobacco plants","volume":"20","author":"Zhang","year":"2002","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.drudis.2016.10.017_bib1005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1007\/s00299-005-0962-8","article-title":"Cloning of Helicobacter pylori urease subunit B gene and its expression in tobacco (Nicotiana tabacum L.)","volume":"24","author":"Gu","year":"2005","journal-title":"Plant Cell Rep."},{"key":"10.1016\/j.drudis.2016.10.017_bib1010","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s11248-008-9186-3","article-title":"Translational fusion of chloroplast-expressed human papillomavirus type 16 L1 capsid protein enhances antigen accumulation in transplastomic tobacco","volume":"17","author":"Lenzi","year":"2008","journal-title":"Transgenic Res."},{"key":"10.1016\/j.drudis.2016.10.017_bib1015","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1128\/IAI.73.12.8266-8274.2005","article-title":"Plant-based vaccine: mice immunized with chloroplast-derived anthrax protective antigen survive anthrax lethal toxin challenge","volume":"73","author":"Koya","year":"2005","journal-title":"Infect. Immun."},{"key":"10.1016\/j.drudis.2016.10.017_bib1020","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1073\/pnas.0503760102","article-title":"Severe acute respiratory syndrome (SARS) S protein production in plants: development of recombinant vaccine","volume":"102","author":"Pogrebnyak","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.10.017_bib1025","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/eji.200425453","article-title":"Protection against tetanus toxin using a plant-based vaccine","volume":"35","author":"Tregoning","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.drudis.2016.10.017_bib1030","doi-asserted-by":"crossref","first-page":"5680","DOI":"10.1073\/pnas.0307420101","article-title":"Induction of oral tolerance to prevent diabetes with transgenic plants requires glutamic acid decarboxylase (GAD) and IL-4","volume":"101","author":"Ma","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.drudis.2016.10.017_bib1035","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/bit.20948","article-title":"Expression of viral capsid protein antigen against Epstein\u2013Barr virus in plastids of Nicotiana tabacum cv. SR1","volume":"94","author":"Lee","year":"2006","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.drudis.2016.10.017_bib1040","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1016\/S0264-410X(03)00428-6","article-title":"Expression of foot-and-mouth disease virus epitopes in tobacco by a tobacco mosaic virus-based vector","volume":"21","author":"Wu","year":"2003","journal-title":"Vaccine"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616304135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644616304135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T12:29:56Z","timestamp":1761222596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644616304135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":104,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S1359644616304135"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2016.10.017","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The next generation of antimicrobial peptides (AMPs) as molecular therapeutic tools for the treatment of diseases with social and economic impacts","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2016.10.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}